ARMO BioSciences Announces Clinical Data Presentations for Immunotherapy AM0010 at ASCO 2017 Annual Meeting – Yahoo Finance
|
ARMO BioSciences Announces Clinical Data Presentations for Immunotherapy AM0010 at ASCO 2017 Annual Meeting
Yahoo Finance REDWOOD CITY, Calif., April 20, 2017 /PRNewswire/ — ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced that five abstracts with clinical data on the Company's lead investigational immuno-oncology drug AM0010 … |
